Acrivastine
Semprex-d (acrivastine) is a small molecule pharmaceutical. Acrivastine was first approved as Semprex-d on 1994-03-25. It is used to treat allergic rhinitis perennial and urticaria in the USA.
| Trade Name | Semprex-d |
|---|---|
| Common Name | Acrivastine |
| Indication | allergic rhinitis perennial, urticaria |
| Drug Class | Antihistaminics (histamine-H1 receptor antagonists) |
